Biofrontera BFRI
NASDAQ BFRI
$1.48 +0.06 (+4.23%)
At close: Aug 20, 2026 · 4:00 PM EDT

Biofrontera (BFRI) Net Margin (2020 - 2026)

Biofrontera (BFRI) posted quarterly Net Margin of 46.04% for Q4 2025, up 5715.0% year-over-year from 0.79% in Q4 2024, and up 148.38% quarter-over-quarter from 95.15% in Q3 2025.

Biofrontera (BFRI) Net Margin (2020 - 2026) Analysis & Trends

Biofrontera's Net Margin history runs 6 years deep, the most recent figure standing at 46.04% for Q4 2025.

  • In Q4 2025, Net Margin rose 5715.0% year-over-year to 46.04%; the TTM figure through Dec 2025 stood at 19.91% (up 2767.0% YoY), while the FY2025 annual figure was 19.91%, up 2767.0% from the prior year.
  • Net Margin for Q4 2025 stood at 46.04%, up from 95.15% in the prior quarter.
  • The five-year high for Net Margin was 97.51% in Q4 2021, with the low at 369.45% in Q3 2021.
  • The 5-year median for Net Margin is 59.16% (2022), against an average of 55.8%.
  • The sharpest annual moves came in 2021 and 2022: Net Margin tumbled 27766 bps in 2021, then jumped 31008 bps in 2022.
  • Biofrontera's Net Margin stood at 97.51% in 2021, then plunged by 128 bps to 27.45% in 2022, then surged by 221 bps to 33.28% in 2023, then plunged by 133 bps to 11.12% in 2024, then soared by 514 bps to 46.04% in 2025.
  • Business Quant data shows BFRI's Net Margin at 46.04% in Q4 2025, 95.15% in Q3 2025, and 58.96% in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -13.91%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 35.09%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 9.28%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 42.51%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -3.16%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 15.06%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 3.95%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Biofrontera 18.87 Mn 14.16 Mn 9.59 Mn -5.03%

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.03%
Dec 31, 2025 46.04%
Sep 30, 2025 -95.15%
Jun 30, 2025 -58.96%
Mar 31, 2025 -48.94%
Dec 31, 2024 -11.12%
Sep 30, 2024 -62.91%
Jun 30, 2024 -3.28%
Mar 31, 2024 -131.91%
Dec 31, 2023 33.28%
Sep 30, 2023 -71.29%
Jun 30, 2023 -168.21%
Mar 31, 2023 -85.63%
Dec 31, 2022 -27.45%
Sep 30, 2022 -59.37%
Jun 30, 2022 -19.07%
Mar 31, 2022 57.03%
Dec 31, 2021 97.51%
Sep 30, 2021 -369.45%
Jun 30, 2021 -62.53%